Use of genome-wide expression data to mine the "Gray Zone" of GWA studies leads to novel candidate obesity genesOSBP-related proteins (ORPs) in human adipose depots and cultured adipocytes: evidence for impacts on the adipocyte phenotypeOne-year treatment with exenatide improves beta-cell function, compared with insulin glargine, in metformin-treated type 2 diabetic patients: a randomized, controlled trialNutritional Modulation of Non-Alcoholic Fatty Liver Disease and Insulin ResistanceDefinitions of Normal Liver Fat and the Association of Insulin Sensitivity with Acquired and Genetic NAFLD-A Systematic ReviewMultiple risk factor intervention in type 2 diabetes: an opportunity not to be missedObesity is associated with impaired platelet-inhibitory effect of acetylsalicylic acid in nondiabetic subjectsExpression of fatty-acid-handling proteins in human adipose tissue in relation to obesity and insulin resistanceGlobal transcript profiles of fat in monozygotic twins discordant for BMI: pathways behind acquired obesityNon-alcoholic fatty liver disease and risk of type 2 diabetes.Acquired obesity is associated with changes in the serum lipidomic profile independent of genetic effects--a monozygotic twin study.Brain metabolic alterations in patients with type 1 diabetes-hyperglycemia-induced injury.Serum total renin, an independent marker of the activity and severity of retinopathy in patients with IDDM.Insulin sensitivity regulates autonomic control of heart rate variation independent of body weight in normal subjects.Non-alcoholic and alcoholic fatty liver disease - two diseases of affluence associated with the metabolic syndrome and type 2 diabetes: the FIN-D2D surveyNutritional modulation of nonalcoholic fatty liver disease and insulin resistance: human data.Comparison of bedtime insulin regimens in patients with type 2 diabetes mellitus. A randomized, controlled trial.Association of lipidome remodeling in the adipocyte membrane with acquired obesity in humans.Altered miRNA processing disrupts brown/white adipocyte determination and associates with lipodystrophy.Exenatide affects circulating cardiovascular risk biomarkers independently of changes in body compositionManagement of type 2 diabetes mellitus and cardiovascular risk: lessons from intervention trials.Different alterations in the insulin-stimulated glucose uptake in the athlete's heart and skeletal muscle.Waist circumference adjusted for body mass index and intra-abdominal fat mass.Adipose tissue gene expression analysis reveals changes in inflammatory, mitochondrial respiratory and lipid metabolic pathways in obese insulin-resistant subjects.Combination therapies with insulin in type 2 diabetes.Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus.Thiazolidinediones.Hyperuricemia and insulin resistance.Kinetics of glucose disposal in whole body and across the forearm in man.Combination therapy with insulin and oral agents: optimizing glycemic control in patients with type 2 diabetes mellitus.Endothelial dysfunction in human diabetes.Strategies to prevent hypoglycaemia during insulin therapy in Type 2 diabetes.Effects of exenatide on measures of β-cell function after 3 years in metformin-treated patients with type 2 diabetesInsulin resistance and endothelial dysfunction.New insulin glargine 300 units/mL versus glargine 100 units/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2).Glucose toxicity.Increased inflammatory activity parallels increased basal nitric oxide production and blunted response to nitric oxide in vivo in rheumatoid arthritis.Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscleSkeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man.Nonglycemic effects of insulin.
P50
Q21144978-24B8EA49-1398-442D-9C05-0E60F5882F95Q24300076-FF8DE7D5-C3BF-4372-8DC8-ABE0717FE0DCQ24656644-F556B5DB-AAA8-4B2D-9949-B82B02A4E073Q26778135-1650D2C6-0880-4E54-B396-EB936C1981A5Q28070408-AB2B3558-D278-4CA8-840F-0F3613531815Q28176265-F0753DAF-B9B3-4E1B-A699-5FD995D4391CQ28196731-D27D6B08-71F3-4C2A-ACF7-9F61B57B5ED8Q28263966-A8811096-8462-4508-B28E-FE49A9F2E676Q28472357-CD0FC980-FC6F-4E1E-AD1F-B30BB4A21362Q30248921-0E5F3144-3526-4DEC-979B-FCF9BE689547Q30829796-3564E536-549C-4FC2-B711-1598A94CC8D6Q30979489-241A787C-ECC6-4BFE-AF55-D0EE59DA8042Q31966601-3E976E1F-7FDE-45A5-9048-397274B7BC1DQ32132717-4CE13265-C14C-44DC-9EF0-A22FC92CF478Q33575324-C81108B5-4819-4F55-991C-E93974271D97Q33692879-6D90874F-40FC-43AA-86CB-6B4E0FA1F981Q33844615-EA751273-FA06-4D38-993E-6F78A8E4C777Q33930538-24F6F7F2-F407-4E8C-BB11-22D3B256712AQ33944314-E5451DC2-9B02-4389-87E7-E45C9555050EQ34015968-235FBCA4-6146-47DE-B050-8161EDD601C3Q34112942-B7B38D04-F542-4823-9666-6AA4DC23011FQ34147396-55A0AC73-455A-475A-B752-921A4283A8E9Q34182363-66D8AEFE-EF7B-4289-B6AF-1599EA6A2E7EQ34218786-D8D9436D-BD5E-476D-9C34-7CFD5E8A8A35Q34227542-6E392023-606C-49F3-B830-670A07164C05Q34255525-AF737105-2529-4227-97FF-902454F26873Q34346862-29E8F30E-B263-4163-9B99-9B2C91936DDEQ34348278-19969316-FCA3-4E67-8666-48B585691325Q34576085-895DBFF4-4283-4B44-BDDB-56ACD321B4E1Q34906478-B984C866-711A-4382-9AF2-F22D137C9BF3Q35087390-BC7DBD4A-EC4C-40B2-BD7A-85A76480ABB5Q35100175-6D092FF9-4300-4C4F-A049-119A9494AAFDQ35179964-ADA48ABD-1959-439E-A5CD-D2DC574DC370Q35214644-E7145084-0CEC-4B37-91EA-9350887B0DCEQ35240456-A98BD46E-CC37-4E24-A7A2-6BA88AD1B972Q35486568-D02A7C34-D23E-4182-8385-3DB74B842D78Q35552814-E6ACAF23-03E8-4471-9D32-51C141765CEAQ35575530-2B235526-41BA-44B0-98CD-48AE89406223Q35577083-63CEB388-9B15-401E-944D-AB42F477BC85Q35676824-D91802D3-63E1-4EC3-BDBC-15E895911213
P50
description
Fins arts
@nl
dokter asal Finlandia
@id
finländsk läkare
@sv
hulumtuese
@sq
investigador
@es
médica finlandesa
@ast
researcher
@en
طبيبة فنلندية
@ar
name
Hannele Yki-Järvinen
@ast
Hannele Yki-Järvinen
@ca
Hannele Yki-Järvinen
@en
Hannele Yki-Järvinen
@es
Hannele Yki-Järvinen
@fi
Hannele Yki-Järvinen
@fr
Hannele Yki-Järvinen
@ga
Hannele Yki-Järvinen
@nl
Hannele Yki-Järvinen
@pt
Hannele Yki-Järvinen
@sl
type
label
Hannele Yki-Järvinen
@ast
Hannele Yki-Järvinen
@ca
Hannele Yki-Järvinen
@en
Hannele Yki-Järvinen
@es
Hannele Yki-Järvinen
@fi
Hannele Yki-Järvinen
@fr
Hannele Yki-Järvinen
@ga
Hannele Yki-Järvinen
@nl
Hannele Yki-Järvinen
@pt
Hannele Yki-Järvinen
@sl
altLabel
H Yki-Jarvinen
@en
H Yki-Järvinen
@en
H. Yki-Jarvinen
@en
H. Yki-Järvinen
@en
Hannele Yki-Jarvinen
@en
Yki-Jarvinen H
@en
Yki-Jarvinen H.
@en
Yki-Jarvinen
@en
Yki-Järvinen H
@en
Yki-Järvinen H.
@en
prefLabel
Hannele Yki-Järvinen
@ast
Hannele Yki-Järvinen
@ca
Hannele Yki-Järvinen
@en
Hannele Yki-Järvinen
@es
Hannele Yki-Järvinen
@fi
Hannele Yki-Järvinen
@fr
Hannele Yki-Järvinen
@ga
Hannele Yki-Järvinen
@nl
Hannele Yki-Järvinen
@pt
Hannele Yki-Järvinen
@sl
P214
P5587
P906
P106
P166
P1960
eaX4TcEAAAAJ
P21
P214
P27
P31
P4854
YkiJaervinenHannele
P496
0000-0001-6766-1549
P5587
dbqstcgx2qcdpb7
P569
1956-01-01T00:00:00Z
P6304
hannele-yki-j%C3%A4rvinen
P734
P735
P7859
viaf-311321440